Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.

Any views on Astrazeneca (AZN)     

Ranjith - 07 Dec 2003 22:31

Got a good line of products, but the share price seem to go down , could it be due to the weak us dollar.

midknight - 13 Feb 2015 12:56 - 46 of 92

Feb 13: Credit Suisse -Neutral - TP: 4670p

midknight - 16 Feb 2015 10:32 - 47 of 92

AZN Airways

midknight - 16 Feb 2015 11:20 - 48 of 92

Astra Zeneca's patent on asthma drug invalidated by US court

midknight - 17 Feb 2015 10:47 - 49 of 92

Astra considering appeal

midknight - 20 Feb 2015 09:52 - 50 of 92

Feb 20: Jefferies: Buy - TP: 5600p

midknight - 24 Feb 2015 09:56 - 51 of 92

Feb 24:

Kepler Cheuvreux: Reduce - TP: 3700p
Credit Suisse: Neutral - TP: 4670p

midknight - 25 Feb 2015 10:39 - 52 of 92

Feb 25:
Citigroup: Buy - TP: 5400p
JP Morgan: Neutral - TP: 4300p

midknight - 10 Mar 2015 10:33 - 53 of 92

Mar 10:
Jefferies:: Buy - TP: 5600p
JP Morgan: Neutral - TP: 4300p



midknight - 11 Mar 2015 09:59 - 54 of 92

Mar 11; Citigroup: Buy - TP: 5400p

midknight - 16 Mar 2015 10:04 - 55 of 92

Mar 16:

Credit Suisse: Neutral - TP: 4320p
Kepler Cheuvreux: Reduce - TP: 3700p
Jefferies: Buy - TP: 5600p
Deutsche Bank: Hold - TP: 4800p

midknight - 17 Mar 2015 10:18 - 56 of 92

Mar 17:
Exane BNP : Outperform - TP: 5400p
Beaufort: Hold
JP Morgan: Neutral

midknight - 01 Apr 2015 10:06 - 57 of 92

Apr 1; Barclays; Underweight - TP: 4770p

midknight - 13 Apr 2015 10:04 - 58 of 92

Apr 13: Jefferies: Buy - TP: 5800p

midknight - 15 Apr 2015 11:31 - 59 of 92

Apr 15:
Kepler Cheuvreaux: Reduce - TP: 3700p
Deutsche Bank: Hold - TP: 4800p

midknight - 15 Apr 2015 12:30 - 60 of 92

FDA grants orphan drug designation for cancer treatment

midknight - 16 Apr 2015 10:11 - 61 of 92

Apr 16
Liberum Capital: Buy - TP: 5800p
Barclays..: Underweight - TP: 4770p
Credit Suisse: Neutral - TP: 4320p
Citigroup: Buy - TP: 5400p
Beaufort Securities: Hol

midknight - 17 Apr 2015 10:25 - 62 of 92

FDA grants another orphan drug designation

17 Apr; Deutsche Bank - Hold - TP up from 4800p to 4850p

midknight - 17 Apr 2015 13:22 - 63 of 92

Apr 17: Societe Generale: Buy - TP: 6600p

midknight - 21 Apr 2015 10:53 - 64 of 92

Apr 21: Barclays retains Underweight - TP up from 4770p to 4850p

midknight - 24 Apr 2015 10:22 - 65 of 92

AZN 1st quarter results
Register now or login to post to this thread.